The Global Apheresis Blog
Exploring the science of therapeutic apheresis, clinical breakthroughs, and what they mean for your health.
Latest from Global Apheresis
Subscribe to the Global Apheresis YouTube channel for the latest on therapeutic plasma exchange, clinical research, and patient stories.
Visit Channel →Articles
August 2026
Guest-Editing a Journal Issue on Where Apheresis Is Going
Dr. Kiprov and I guest-edited the August 2026 theme issue of Transfusion and Apheresis Science. Five articles on where the field is heading — and why we think the word for it is precision apheresis.
Read Article →
May 2026
Can Plasma Dilution Help a Heart Recover? New Research from UC Berkeley
A new paper from the Conboy lab at UC Berkeley shows that a single plasma dilution procedure 24 hours after a heart attack preserved cardiac function, exercise capacity, and tissue health in aged mice for three months.
Read Article →
April 2026
ASFA 2026 in Denver: TPE, Longevity, and a Field at an Inflection Point
At ASFA 2026 in Denver, the longevity and microplastics sessions drew some of the largest crowds in the program. The center of the field is moving.
Read Article →
April 2026
What the Firefighter Study Tells Us About Removing "Forever Chemicals" From Your Blood
PFAS "forever chemicals" are now linked to fertility loss and fetal abnormalities. Here's what a randomized trial in firefighters tells us about how to reduce them.
Read Article →
April 2026
Therapeutic Plasma Exchange at WIRM World Congress 2026
Dr. Dobri Kiprov presents on plasmapheresis and therapeutic plasma exchange at the WIRM World Congress 2026 in San Francisco. Here is why regenerative medicine is paying attention to TPE.
Read Article →
April 2026
Plasmapheresis vs. EBOO: What Patients Should Know
EBOO is marketed as a blood-cleansing alternative to plasmapheresis. But its filter doesn't separate plasma, its 'detox' evidence is likely fibrin clots, and its mechanism causes oxidative stress, the opposite of what TPE achieves.
Read Article →
March 2026
The AMBAR Trial: What It Means for Alzheimer's Patients and Families
The AMBAR trial showed therapeutic plasma exchange slowed Alzheimer's progression by 52–71%. Here's what the data means for patients and families.
Read Article →
March 2026
What Joe Rogan Got Right About Plasmapheresis
Joe Rogan posted about plasmapheresis to millions of followers. Here's what the science actually says, from a practice that's performed over 15,000 procedures.
Read Article →
March 2026
CIRS Treatment with Plasmapheresis: A New Approach to Chronic Inflammatory Response Syndrome
Jordan Peterson's CIRS diagnosis put a name on a condition millions live with undiagnosed. At Global Apheresis, we're treating CIRS with plasmapheresis — addressing what oral protocols cannot.
Read Article →
March 2026
Therapeutic Plasma Exchange at the Global Longevity Federation 2026 in Rome
Dr. Dobri Kiprov presented on therapeutic plasma exchange for healthspan extension at the Global Longevity Federation 2026 in Rome, Italy.
Read Article →
March 2026
What Is Inuspheresis — And How Does It Compare to TPE?
Inuspheresis is generating significant interest among patients researching apheresis therapy. Here's what it is, where it's available, and how it compares to TPE.
Read Article →
March 2026
What to Expect During Your First TPE Session
From preparation to recovery, a step-by-step guide to help you feel prepared and comfortable before your first therapeutic plasma exchange session.
Read Article →
March 2026
How Therapeutic Plasma Exchange Reduces Biological Age
A 2022 GeroScience study and a 2025 Buck Institute multi-omics analysis confirm that therapeutic plasma exchange measurably reduces biological age. Here's what the science shows and what it means for patients.
Read Article →Have Questions? Talk to a Physician
Schedule a free discovery call with our physicians to discuss whether therapeutic apheresis is right for you.
Book a Free Discovery Call